NCT05316701 2026-03-04
Orca-T
Orca Biosystems, Inc.
Phase 3 Active not recruiting
Clinical Trials
63 trialsNCT03763838 2026-02-05
Acupressure for Fatigue in Ovarian Cancer Survivors
University of Michigan Rogel Cancer Center
Phase NA Completed
NCT04870515 2026-01-09
Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study
Fred Hutchinson Cancer Center
Phase NA Completed
NCT03602859 2025-12-31
FIRST
Tesaro, Inc.
Phase 3 Active not recruiting
NCT03745794 2025-12-23
Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery
M.D. Anderson Cancer Center
Phase 2 Completed
NCT03422198 2025-12-12
SAVE
University of Utah
Phase 3 Recruiting
NCT04905082 2025-12-11
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
Phase NA Active not recruiting
NCT01723774 2025-12-09
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Washington University School of Medicine
Phase 2 Active not recruiting
NCT04986566 2025-12-05
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
City of Hope Medical Center
Phase NA Active not recruiting
NCT03778931 2025-09-15
EMERALD
Stemline Therapeutics, Inc.
Phase 3 Completed
NCT03022032 2025-09-09
The HOPE Trial and the SMART Study
Dana-Farber Cancer Institute
Phase NA Completed
NCT04889144 2025-09-09
PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning
Fred Hutchinson Cancer Center
Phase NA Completed
NCT04596384 2025-08-19
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
City of Hope Medical Center
Phase NA Active not recruiting
NCT03575351 2025-08-03
TRANSFORM
Celgene
Phase 3 Completed
NCT03194646 2025-07-28
ASTEROID 6
Bayer
Phase 3 Terminated
NCT06504524 2025-06-27
A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US
Pfizer
Completed
NCT03820544 2025-04-30
SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice
Thomas Jefferson University
Phase NA Terminated
NCT04989504 2025-04-29
Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy
Alliance for Clinical Trials in Oncology
Phase 3 Active not recruiting
NCT04032106 2025-03-14
HPV Vaccine Intervention for Young Sexual Minority Men
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03125070 2025-01-29
INSPIRE
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT03154190 2025-01-24
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
Phase NA Completed
NCT02630823 2025-01-03
MK-3475 Immunotherapy in Endometrial Carcinoma
Washington University School of Medicine
Phase 1 Completed
NCT05236257 2024-12-10
EPI VITRAKVI
Bayer
Completed
NCT05932290 2024-10-29
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT03217071 2024-10-23
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
University of California, San Francisco
Phase 2 Completed
NCT03244826 2024-08-16
Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
Dana-Farber Cancer Institute
Phase NA Completed
NCT04497142 2024-08-05
Effect of Perampanel on Peritumoral Hyperexcitability in HGG
Dana-Farber Cancer Institute
Phase 1/2 Completed
NCT05565391 2024-05-21
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
Pfizer
Completed
NCT03887702 2024-05-20
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
SWOG Cancer Research Network
Phase 3 Terminated
NCT02956473 2024-03-12
Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy
Dana-Farber Cancer Institute
Phase NA Completed
NCT01995708 2024-02-09
CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT04496219 2024-01-02
Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT05810714 2023-12-05
Audio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in Appalachia
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT03641287 2023-11-29
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors
University of Washington
Phase NA Terminated
NCT00769652 2023-10-03
Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
Rutgers, The State University of New Jersey
Phase NA Terminated
NCT02101385 2023-09-28
Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Hoosier Cancer Research Network
Phase 2 Completed
NCT04099888 2023-09-11
RELEASE
PCI Biotech AS
Phase 2 Terminated
NCT03182998 2023-08-02
Decision Aids to Improve Knowledge in Patients With Prostate Cancer
Mayo Clinic
Phase NA Completed
NCT00556374 2023-07-27
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
Amgen
Phase 3 Completed
NCT02784288 2023-06-27
Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT04000581 2022-07-22
Impact of Early Mobility on Post-Surgery Recovery in Patients Undergoing Oncologic Surgeries
Roswell Park Cancer Institute
Phase NA Terminated
NCT03329690 2022-03-18
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]
Daiichi Sankyo
Phase 2 Completed
NCT04446429 2021-12-10
Anti-Androgen Treatment for COVID-19
Applied Biology, Inc.
Phase NA Completed
NCT02592447 2021-11-16
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT03393000 2021-07-22
INTACT
Diffusion Pharmaceuticals Inc
Phase 3 Terminated
NCT02448810 2021-05-25
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer
Takeda
Phase 2 Terminated
NCT03016403 2021-03-19
A Stepped Care Intervention to Reduce Disparities in Mental Health Services Among Cancer Patients and Caregivers
University of Colorado, Denver
Phase NA Completed
NCT01883362 2021-03-17
RADIUS
Novartis
Phase 2 Completed
NCT02039726 2021-02-24
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
Daiichi Sankyo
Phase 3 Completed
NCT02369874 2021-02-10
EAGLE
AstraZeneca
Phase 3 Completed